Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUGEAS: Ticagrelor vs Clopidogrel on Coronary Flow Reserve in T2DM
NCT04069234Phase 3Withdrawn
- Sponsor
- Region Skåne
- Start
- Sep 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD), sponsored by Region Skåne. Planned start Sep 2019; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04069234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069234.